OtoNexus (Seattle) has raised more than $4.4 million as it continues to develop its ultrasound medical device technology to diagnose middle ear infections, according to a U.S. Securities and Exchange Commission Form D filed this month.
OtoNexus has been seeking a nearly $8.3 million from the money-raise. It previously raised $7.8 million in 2017.
Get the full story on our sister site Medical Design & Outsourcing.
